These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25931819)

  • 1. Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy.
    Wu J; Wang Y; Wang Y; Zhao M; Zhang X; Gui L; Zhao S; Zhu H; Zhao J; Peng S
    Int J Nanomedicine; 2015; 10():2925-38. PubMed ID: 25931819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
    Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
    Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide.
    Jin S; Wang Y; Zhu H; Wang Y; Zhao S; Zhao M; Liu J; Wu J; Gao W; Peng S
    ACS Nano; 2013 Sep; 7(9):7664-73. PubMed ID: 23931063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
    Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
    Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of complexation of Cu(II) with P6A peptide and its analogs on their thrombolytic activities.
    Yang M; Cui G; Zhao M; Wang C; Wang L; Liu H; Peng S
    Int J Pharm; 2008 Oct; 362(1-2):81-7. PubMed ID: 18625295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing L-Arg and L-Asp or L-Glu.
    Chen Y; Cui G; Zhao M; Wang C; Qian K; Morris-Natschke S; Lee KH; Peng S
    Bioorg Med Chem; 2008 Jun; 16(11):5914-25. PubMed ID: 18495483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-base properties of the (1-4,18-36) fragments of neuropeptide K and their mono- and polynuclear copper(II) complexes products of metal-catalyzed oxidation.
    Błaszak M; Jankowska E; Kowalik-Jankowska T
    Inorg Chem; 2013 Jan; 52(1):130-43. PubMed ID: 23244738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arg-Gly-Asp-Ser peptide analogs suppress cartilage chondrolytic activities of integrin-binding and nonbinding fibronectin fragments.
    Homandberg GA; Hui F
    Arch Biochem Biophys; 1994 Apr; 310(1):40-8. PubMed ID: 8161219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability assessment of a new antithrombotic small peptide, Arg-Gly-Asp-Trp-Arg (RGDWR), and its derivative.
    Yang L; Zhang L; Yan L; Zheng H; Lu P; Chen J; Dai J; Sun H; Xu Y; Yang T
    Biotechnol Lett; 2017 Aug; 39(8):1183-1190. PubMed ID: 28497174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
    Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA
    J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Cu(II)-Arg-Gly-His-Xaa metallopeptides with DNA: effect of C-terminal residues, Leu and Glu.
    Nagane R; Koshigoe T; Chikira M
    J Inorg Biochem; 2003 Jan; 93(3-4):204-12. PubMed ID: 12576283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 1,5-disubstituted tetrazole ring on chelating ability of delta-selective opioid peptide.
    Łodyga-Chruścińska E; Ołdziej S; Micera G; Sanna D; Chruściński L; Olczak J; Zabrocki J
    J Inorg Biochem; 2004 Mar; 98(3):447-58. PubMed ID: 14987845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences.
    Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous resolution of binary copper(II) complexes with racemic dipeptides: crystal structures of glycyl-L-alpha-amino-n-butyrato copper(II) monohydrate, glycyl-D-valinato copper(II) hemihydrate, and glycyl-L-valinato copper(II) hemihydrate.
    Inomata Y; Yamaguchi T; Tomita A; Yamada D; Howell FS
    J Inorg Biochem; 2005 Aug; 99(8):1611-8. PubMed ID: 15963569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo ultrasound molecular imaging of inflammatory thrombosis in arteries with cyclic Arg-Gly-Asp-modified microbubbles targeted to glycoprotein IIb/IIIa.
    Wu W; Wang Y; Shen S; Wu J; Guo S; Su L; Hou F; Wang Z; Liao Y; Bin J
    Invest Radiol; 2013 Nov; 48(11):803-12. PubMed ID: 23857134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
    Cadroy Y; Houghten RA; Hanson SR
    J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
    Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
    J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordination of copper(II) ions by the fragments of neuropeptide gamma containing D1, H9, H12 residues and products of copper-catalyzed oxidation.
    Jankowska E; Pietruszka M; Kowalik-Jankowska T
    Dalton Trans; 2012 Feb; 41(6):1683-94. PubMed ID: 22159001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.